CN1709326A - 一种治疗乳腺增生疾病的浓缩丸制备方法 - Google Patents
一种治疗乳腺增生疾病的浓缩丸制备方法 Download PDFInfo
- Publication number
- CN1709326A CN1709326A CN 200510016914 CN200510016914A CN1709326A CN 1709326 A CN1709326 A CN 1709326A CN 200510016914 CN200510016914 CN 200510016914 CN 200510016914 A CN200510016914 A CN 200510016914A CN 1709326 A CN1709326 A CN 1709326A
- Authority
- CN
- China
- Prior art keywords
- radix
- pill
- preparation
- cornu cervi
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006187 pill Substances 0.000 title claims abstract description 28
- 210000005075 mammary gland Anatomy 0.000 title claims abstract description 6
- 238000000034 method Methods 0.000 title claims description 8
- 201000010099 disease Diseases 0.000 title description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 3
- 230000035755 proliferation Effects 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 21
- 229920002472 Starch Polymers 0.000 claims abstract description 15
- 239000008107 starch Substances 0.000 claims abstract description 15
- 235000019698 starch Nutrition 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 239000012528 membrane Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000000926 separation method Methods 0.000 claims abstract description 8
- 206010020718 hyperplasia Diseases 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 13
- 241000180649 Panax notoginseng Species 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241000195474 Sargassum Species 0.000 claims description 7
- 241000628997 Flos Species 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000008517 radix Trichosanthis Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 230000004907 flux Effects 0.000 claims description 4
- 230000014759 maintenance of location Effects 0.000 claims description 4
- 229920002492 poly(sulfone) Polymers 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 20
- 238000010298 pulverizing process Methods 0.000 abstract description 3
- 238000005303 weighing Methods 0.000 abstract description 2
- 241001530126 Scrophularia Species 0.000 abstract 1
- 241000245665 Taraxacum Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 239000002547 new drug Substances 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100169148A CN1318058C (zh) | 2005-06-23 | 2005-06-23 | 一种治疗乳腺增生疾病的浓缩丸制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100169148A CN1318058C (zh) | 2005-06-23 | 2005-06-23 | 一种治疗乳腺增生疾病的浓缩丸制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1709326A true CN1709326A (zh) | 2005-12-21 |
CN1318058C CN1318058C (zh) | 2007-05-30 |
Family
ID=35705658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100169148A Active CN1318058C (zh) | 2005-06-23 | 2005-06-23 | 一种治疗乳腺增生疾病的浓缩丸制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1318058C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100382818C (zh) * | 2005-09-09 | 2008-04-23 | 沈阳中药制药有限公司 | 一种治疗乳腺囊性增生及乳腺炎的中药及其糖衣片的制备方法 |
CN100391444C (zh) * | 2005-12-29 | 2008-06-04 | 辽宁好护士药业(集团)有限责任公司 | 乳癖消软胶囊及其制备方法 |
CN105381122A (zh) * | 2015-11-30 | 2016-03-09 | 潘素荣 | 治疗乳腺增生的软坚散结制剂及制法 |
CN106138675A (zh) * | 2016-08-30 | 2016-11-23 | 黄再军 | 一种治疗慢性咽炎的浓缩丸及其制备方法 |
CN111297971A (zh) * | 2019-12-27 | 2020-06-19 | 辽宁上药好护士药业(集团)有限公司 | 一种用于治疗乳腺癌组合物及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100350933C (zh) * | 2003-07-15 | 2007-11-28 | 何清源 | 乳癖熨剂及其制备方法 |
-
2005
- 2005-06-23 CN CNB2005100169148A patent/CN1318058C/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100382818C (zh) * | 2005-09-09 | 2008-04-23 | 沈阳中药制药有限公司 | 一种治疗乳腺囊性增生及乳腺炎的中药及其糖衣片的制备方法 |
CN100391444C (zh) * | 2005-12-29 | 2008-06-04 | 辽宁好护士药业(集团)有限责任公司 | 乳癖消软胶囊及其制备方法 |
CN105381122A (zh) * | 2015-11-30 | 2016-03-09 | 潘素荣 | 治疗乳腺增生的软坚散结制剂及制法 |
CN106138675A (zh) * | 2016-08-30 | 2016-11-23 | 黄再军 | 一种治疗慢性咽炎的浓缩丸及其制备方法 |
CN106138675B (zh) * | 2016-08-30 | 2019-11-15 | 黄再军 | 一种治疗慢性咽炎的浓缩丸及其制备方法 |
CN111297971A (zh) * | 2019-12-27 | 2020-06-19 | 辽宁上药好护士药业(集团)有限公司 | 一种用于治疗乳腺癌组合物及其制备方法和应用 |
CN111297971B (zh) * | 2019-12-27 | 2021-10-08 | 辽宁上药好护士药业(集团)有限公司 | 一种用于治疗乳腺癌组合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1318058C (zh) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1857690A (zh) | 妇科病制剂及新的制备方法 | |
CN104826016B (zh) | 一种治疗乳腺增生的药物组合物及其制备方法和用途 | |
CN101773637A (zh) | 一种广谱抗病毒纳米中药及其生产方法 | |
CN1318058C (zh) | 一种治疗乳腺增生疾病的浓缩丸制备方法 | |
CN102657736B (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法 | |
CN1330345C (zh) | 一种治疗高血脂症的中药组合物及其制备方法 | |
CN1814124A (zh) | 一种滋阴补肾益气活血的地黄制剂 | |
CN100371012C (zh) | 一种药物组合物及其制备方法和用途 | |
CN1927324A (zh) | 用于治疗妇女月经不调中药制剂的制备方法 | |
CN101549075B (zh) | 一种治疗乳腺增生的中药组合物及其制备方法 | |
CN1814217B (zh) | 一种治疗风湿关节炎的中药组合物及其制备方法 | |
CN103127272A (zh) | 一种治疗乳腺疾病的中药制剂及其制备方法 | |
CN1313118C (zh) | 治疗乳腺增生中药速释浓缩丸的制备方法 | |
CN102188580B (zh) | 治疗乳腺小叶增生的中药外用药组合物和巴布膏剂及制备方法 | |
CN101194959B (zh) | 一种治疗头痛的胶囊及其制备方法 | |
CN113058013A (zh) | 一种中药组合物及其制备方法和应用 | |
CN1205948C (zh) | 一种治疗乳腺增生的内服药 | |
CN104491318A (zh) | 一种治疗哮喘的中药制剂及其制备方法 | |
CN103989940A (zh) | 一种治疗糖尿病的中药组合物 | |
CN101700323B (zh) | 一种防治肝癌的药物组合物 | |
CN101194958B (zh) | 一种治疗头痛的煎膏剂的制备方法 | |
CN100473403C (zh) | 一种治疗癌症的胶囊 | |
CN1709478A (zh) | 治疗妇科疾病中药制剂的制备方法 | |
CN1319583C (zh) | 一种治疗肺癌的药物及其制备方法 | |
CN1261146C (zh) | 一种用于治疗妇女乳腺增生类疾症的外用中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Beijing Pharmaceutical Co., Ltd. Assignor: Xiu Laigui Contract fulfillment period: 2008.6.28 to 2018.6.27 Contract record no.: 2009110000066 Denomination of invention: Method for preparing concentrated pill for treating mammary gland proliferation disease Granted publication date: 20070530 License type: Exclusive license Record date: 20090505 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.6.28 TO 2018.6.27; CHANGE OF CONTRACT Name of requester: XIUZHENG PHARMACEUTICAL INDUSTRY GROUP BEIJING XIU Effective date: 20090505 |
|
ASS | Succession or assignment of patent right |
Owner name: TONGYAO PHARMACEUTICAL GROUP STOCK CO., LTD. Free format text: FORMER OWNER: XIU LAIGUI Effective date: 20150525 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 130012 CHANGCHUN, JILIN PROVINCE TO: 134000 TONGHUA, JILIN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150525 Address after: 134000 amendment Road 39, Jilin, Tonghua Patentee after: Tongyao Pharmaceutical Group Corporation Address before: 130012 No. 2426 Qianjin Street, Changchun hi tech Development Zone, Jilin, China Patentee before: Xiu Laigui |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Concentrated pill preparation method for treating mammary gland hyperplasia disease Effective date of registration: 20201126 Granted publication date: 20070530 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: Tongyao Pharmaceutical Group Corp. Registration number: Y2020220000086 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211221 Granted publication date: 20070530 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: Tongyao Pharmaceutical Group Corp. Registration number: Y2020220000086 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |